MediWound Ltd. (MDWD) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Yavne, 以色列. 现任CEO为 Ofer Gonen.
MDWD 拥有 IPO日期为 2014-03-20, 111 名全职员工, 在 NASDAQ Global Market, 市值为 $187.38M.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
